home / stock / ctdh / ctdh quote
Last: | $0.086 |
---|---|
Change Percent: | 36.51% |
Open: | $0.066 |
Close: | $0.086 |
High: | $0.099 |
Low: | $0.0631 |
Volume: | 356,808 |
Last Trade Date Time: | 12/08/2020 04:54:47 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.086 | $0.066 | $0.086 | $0.099 | $0.0631 | 356,808 | 12-08-2020 |
$0.063 | $0.065 | $0.063 | $0.065 | $0.055 | 406,421 | 12-07-2020 |
$0.063 | $0.073 | $0.063 | $0.08 | $0.06 | 452,996 | 12-04-2020 |
$0.075 | $0.061 | $0.075 | $0.08 | $0.059 | 451,775 | 12-03-2020 |
$0.0736 | $0.085 | $0.0736 | $0.085 | $0.0585 | 2,022,770 | 12-02-2020 |
$0.085 | $0.08 | $0.085 | $0.105 | $0.08 | 924,696 | 12-01-2020 |
$0.08 | $0.0725 | $0.08 | $0.095 | $0.0661 | 383,120 | 11-30-2020 |
$0.075 | $0.07005 | $0.075 | $0.075 | $0.0651 | 270,900 | 11-27-2020 |
$0.065 | $0.0795 | $0.065 | $0.0825 | $0.06 | 659,089 | 11-26-2020 |
$0.065 | $0.0795 | $0.065 | $0.0825 | $0.06 | 659,089 | 11-25-2020 |
$0.076 | $0.085 | $0.076 | $0.0875 | $0.072 | 234,200 | 11-24-2020 |
$0.082 | $0.0699 | $0.082 | $0.084 | $0.065 | 307,408 | 11-23-2020 |
$0.06 | $0.0499 | $0.06 | $0.069 | $0.0499 | 1,480,156 | 11-20-2020 |
$0.045 | $0.08 | $0.045 | $0.084 | $0.034 | 4,646,672 | 11-19-2020 |
$0.08 | $0.109 | $0.08 | $0.109 | $0.072 | 727,821 | 11-18-2020 |
$0.109 | $0.1109 | $0.109 | $0.1145 | $0.1 | 364,933 | 11-17-2020 |
$0.1109 | $0.11 | $0.1109 | $0.1139 | $0.106 | 86,180 | 11-16-2020 |
$0.11 | $0.1119 | $0.11 | $0.1119 | $0.105 | 51,917 | 11-13-2020 |
$0.1119 | $0.105 | $0.1119 | $0.112 | $0.105 | 36,450 | 11-12-2020 |
$0.105 | $0.114 | $0.105 | $0.114 | $0.105 | 63,500 | 11-11-2020 |
News, Short Squeeze, Breakout and More Instantly...
Conference Brings Together Medical Researchers and Health Professionals to Exchange Information on Lysosomal Diseases Cyclo Therapeutics, Inc. (OTCQB: CTDH), a clinical stage biotechnology company developing a cyclodextrin platform for the treatment of Neurodegenerative Diseases...
Cyclo Therapeutics will now proceed in the US with its Phase 3 clinical trial of Trappsol ® Cyclo™ for treatment of Niemann-Pick Disease Type C Cyclo Therapeutics, Inc. (OTCQB: CTDH), a clinical stage biotechnology company developing a cyclodextrin platform for t...
Cyclo Therapeutics is proud to sponsor the conference for the 5 th consecutive year Cyclo Therapeutics, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C (NPC) and Alzheimer...